HYSTEROSCOPIC MYOMECTOMY
Leiomyomas are the most common pelvic tumors. Submucosal fibroids are a common cause of abnormal bleeding and infertility. Hysteroscopic myomectomy is the definitive management of symptomatic submucosal fibroids, with high efficacy and safety. Several techniques have been introduced over time and wi...
Main Authors: | Ricardo Bassil Lasmar, Bernardo Portugal Lasmar, Nash S. Moawad |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/58/11/1627 |
Similar Items
-
The (cost) effectiveness of procedural sedation and analgesia versus general anaesthesia for hysteroscopic myomectomy, a multicentre randomised controlled trial: PROSECCO trial, a study protocol
by: Julia F. van der Meulen, et al.
Published: (2019-03-01) -
The role of hormone therapy before hysteroscopic myomectomy
by: Antonio Simone Laganà, et al.
Published: (2021-12-01) -
Uterine submucosal leiomyomas: modern diagnosis and miniinvasive surgery
by: Oana Denisa Balalau, et al.
Published: (2021-11-01) -
Review of myomectomy
by: Huann-Cheng Horng, et al.
Published: (2012-03-01) -
Evaluation of the timing and safety of hysteroscopic myomectomy of large submucosal fibroids pretreated by high intensity focused ultrasound
by: Kaiyin Qu, et al.
Published: (2023-12-01)